The value of a second injection on the pharmaco-induced erection test

Area of Science:

• Urology
• Andrology
• Pharmacology

Background:

• Pharmacological erection is a common treatment for erectile dysfunction.
• Incomplete responses to initial intracavernosal injections can occur.
• Optimizing treatment for erectile dysfunction requires exploring methods to enhance erection quality.

Purpose of the Study:

• To evaluate the efficacy of a second intracavernosal injection in improving incomplete pharmacologically induced erections.
• To determine if a higher dose combination therapy can salvage suboptimal erectile responses.

Main Methods:

• Thirty impotent patients with incomplete erectile responses to an initial dose of prostaglandin E1 (PGE1) and phentolamine were studied.
• A second injection containing a higher concentration of PGE1, phentolamine, and papaverine was administered 15 minutes after the first.
• Erectile response was assessed after the second injection.

Main Results:

• Twenty-one out of 30 patients (70%) showed improvement in their erection after the second injection.
• Nine patients (30%) achieved complete penile rigidity following the reinjection.
• The second injection successfully salvaged incomplete erections in a significant proportion of patients.

Conclusions:

• Reinjection with an enhanced pharmacological regimen is a viable strategy to improve incomplete pharmacologically induced erections.
• This approach offers a potential solution for patients experiencing suboptimal responses to initial erectile dysfunction treatments.
• Intracavernosal reinjection can frequently salvage and improve erectile function in cases of initial treatment failure.